Abstract
The aim of this study was to determine long-term efficacy and safety subcutaneous injection of interferon-alpha-2B in patients with mumps orchitis in terms of testicular volume and other testicular functions. Mumps orchitis was evaluated in 37 patients. Patients were hospitalized and administered 1 × 3,000,000 IU subcutaneous injection of interferon-alpha-2B daily for 7 days. The testicular volumes of all the patients were measured by ultrasonography in the 18th month following treatment termination. The testes volumes were evaluated by descriptive statistics as percentages. Patients were divided into three groups according to testes volumes and differences between the involved and non-involved testicles. Group I included patients with normal testes volume (>12 ml) and a difference between testes of less than 2 ml or 20%; Group II (atrophic groups) included patients with testes volume of less than 12 ml; and Group III (hypotrophic groups) included patients with testes volume of greater than 12 ml and a difference between testes of more than 2 ml or 20%. Groups were compared in terms of results of semen analysis and serum follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels. Patients’ ages ranged between 17 and 41 years (mean: 28.3 years). A total of nine atrophy cases were identified. Sixteen patients were determined to have hypotrophic testes with a difference of 2–10 ml or 20% between the involved and non-involved testicles, despite the absence of testicular atrophy. A comparison of groups revealed that sperm density, total sperm count, total motile sperm count, and motility percentage were significantly higher in Group I than in the other groups, while serum FSH and LH levels were lower in Group I than in the other groups. Although the use of interferon-alpha-2B appears to prevent testicular atrophy and protect testicular function, it leads to a considerable difference in the volume between testicles and a significant loss of testicular function. As a result, further studies are required in order to investigate the efficacy of the drug.
Similar content being viewed by others
References
Litman N, Baum SG (1999) Mumps virus, part III infectious diseases and their etiologic agents principles and practise of infectious disease, 5th edn. Churchill Livingstone, London, pp 1496–1500
Basekim CC, Kizilkaya E, Pekkafali Z, Baykal KV, Karsli AF (2000) Mumps epididymo-orchitis: sonography and color Doppler sonographic findings. Abdom Imaging 25:322–325
Erpenbach KHJ (1991) Systemic treatment with interferon alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis. J Urol 146:54–56
Lane TM, Hines J (2006) The management of mumps orchitis. BJU Int 97:1–2
Burhans RA (1945) Treatment of mumps orchitis. J Urol 54:547
Ku JH, Kim YH, Jeon YS, Lee NK (1999) The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis. BJU Int 84:839–842
Sakamoto H, Saito K, Oohta M, Inoue K, Ogawa Y, Yoshida H (2007) Testicular volume measurement: comparison of ultrasonography, orchidometry, and water displacement. Urology 69:152–157
Yalti S, Gürbüz B, Fiçicioglu C (2002) Serum levels of inhibin B in men and their relationship with gonadal hormones, testicular volume, testicular biopsy results and sperm parameters. J Obstet Gynaecol 22:649–654
Cayan S, Woodhouse CR (2007) The treatment of adolescents presenting with a varicocele. BJU Int 100:744–747
Singh R, Mostafid H, Hindley RG (2006) Measles, mumps and rubella the urologist’s perspective. Int J Clin Pract 60:335–339
Hrynash Y, Nadraga A, Dasho M (2008) Effectiveness of a vaccination program against mumps in Ukraine. Eur J Clin Microbiol Infect Dis 27:1171–1176
Dominguez A, Oviedo M, Torner N et al (2009) Mumps: a year of enhanced surveillance in Catalonia, Spain. Vaccine 27:3492–3495
Beard CM, Benson RC Jr, Kelalis PP, Elveback LR, Kurland LT (1977) The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935–1974. Mayo Clin Proc 52:3–7
Vaughan VC (1922) Epidemiology and public health. A text and reference book for physicians, medical students and health workers. Henry Kimpton, London
Phillips CF (1979) Mumps. In: Vaughn VC, McKay Jr RJ, Behrman RE, Nelson WE (eds) Nelson’s textbook of pediatrics. W.B. Saunders Co., Philadelphia, 79 pp
Green GF (1964) Mumps orchitis in childhood. Practitioner 192:550–552
Nickel WR, Plumb RT (1986) Mumps orchitis. In: Harrison JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC (eds) Campbells urology. W.B. Saunders Co., Philadelphia, pp 977–978
Yeniyol CO, Sorguc S, Minareci S, Ayder AR (2000) Role of interferon-alpha-2B in prevention of testicular atrophy with unilateral mumps orchitis. Urology 55:931–933
Philip J, Selvan D, Desmond AD (2006) Mumps orchitis in the non-immune postpubertal male: a resurgent threat to male fertility? BJU Int 97:138–141
Freeman BA (1979) Mumps virus. In: Freeman BA (ed) Textbook of microbiology. W.B. Saunders Co., Philadelphia, pp 1001–1003
Bjorvatn B (1973) Mumps virus recovered from testicles by fine-needle aspiration biopsy in cases of mumps orchitis. Scand J Infect Dis 5:3–7
Bartak V (1973) Sperm count, morphology and motility after unilateral mumps orchitis. J Reprod Fertil 32:491–494
Bertschat FL, Alexander M (1981) Infertility after mumps orchitis (author’s translation). MMW Munch Med Wochenschr 123:606–608
Lapides J, Herwig KR, Anderson EC, Lovegrove RH, Correa RJ, Sloan JB (1967) Oxyphenbutazone therapy for mumps orchitis, acute epididymitis and osteitis pubis. J Urol 98:528–530
Prader A (1966) Testicular size: assessment and clinical importance. Triangle 7:240–243
Arai T, Kitahara S, Horiuchi S, Sumi S, Yoshida K (1998) Relationship of testicular volume to semen profiles and serum hormone concentrations in infertile Japanese males. Int J Fertil Womens Med 43:40–47
Sakamoto H, Ogawa Y, Yoshida H (2008) Relationship between testicular volume and testicular function: comparison of the Prader orchidometric and ultrasonographic measurements in patients with infertility. Asian J Androl 10:319–324
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yapanoglu, T., Kocaturk, H., Aksoy, Y. et al. Long-term efficacy and safety of interferon-alpha-2B in patients with mumps orchitis. Int Urol Nephrol 42, 867–871 (2010). https://doi.org/10.1007/s11255-010-9737-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-010-9737-4